Spectrum Levoleucovorin approved by FDA
Spectrum Pharmaceuticals Inc. has received FDA approval for Levoleucovorin as a treatment for osteosarcoma. The drug has been approved for use after high-dose methotrexate therapy and to counteract the effects of impaired methotrexate elimination and an overdose of folic acid antagonists. The company intends to apply for FDA approval of Levoleucovorin in colon cancer and as an oral tablet by mid 2008.
- FDA approves Duramed’s LoSEASONIQUE(R) oral contraceptive
- FDA approves new formulation Vaprisol
- Entereg approved to restore bowel function post surgery
- FDA OKs Nexium in children ages 1 to 11
